Evidence map›Paper›PMID 35045174›Full record

ArticleDiabetes care2022

The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control.

Smadar Shilo, Anastasia Godneva, Marianna Rachmiel, Tal Korem, Yuval Bussi, Dmitry Kolobkov, Tal Karady, Noam Bar, Bat Chen Wolf, Yitav Glantz-Gashai and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Metagenomic Insights into Gut Microbiota Alterations FollowingInternational journal of molecular sciences · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Gut microbiota alteration was related to subclinical hypothyroidism and dyslipidemia in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  18. Article
  19. Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes.The Journal of clinical endocrinology and metabolism · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Smadar ShiloDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Anastasia GodnevaDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Marianna RachmielPediatric Endocrinology Unit, Shamir Medical Center, Zerifin, Israel.
Tal KoremDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Yuval BussiDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Dmitry KolobkovDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Tal KaradyDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Noam BarDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Bat Chen WolfDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Yitav Glantz-GashaiPediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.
Michal CohenPediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.
Nehama Zuckerman-LevinPediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.
Naim ShehadehPediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.
Noah GruberSackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Neriya LevranPediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.
Shlomit KorenSackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.ORCID 0000-0003-0676-8865
Adina WeinbergerDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Orit Pinhas-HamielSackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.ORCID 0000-0001-8365-8091
Eran SegalDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-6859-1164
Weizmann Institute of Science · ILRambam Health Care Campus · ILTel Aviv University · ILHebrew University of Jerusalem · IL

Funding

Linking microbiome genetic variants with cardiovascular phenotypes in 50,000 individualsR01HL160862 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI POLLARD, KATHERINE S. · 2022 to 2025
$2.7M
NHLBI NIH HHS R01 HL160862
6 · The paper itself

Abstract

objectivePrevious studies have demonstrated an association between gut microbiota composition and type 1 diabetes (T1D) pathogenesis. However, little is known about the composition and function of the gut microbiome in adults with longstanding T1D or its association with host glycemic control. RESEARCH DESIGN AND

methodsWe performed a metagenomic analysis of the gut microbiome obtained from fecal samples of 74 adults with T1D, 14.6 ± 9.6 years following diagnosis, and compared their microbial composition and function to 296 age-matched healthy control subjects (1:4 ratio). We further analyzed the association between microbial taxa and indices of glycemic control derived from continuous glucose monitoring measurements and blood tests and constructed a prediction model that solely takes microbiome features as input to evaluate the discriminative power of microbial composition for distinguishing individuals with T1D from control subjects.

resultsAdults with T1D had a distinct microbial signature that separated them from control subjects when using prediction algorithms on held-out subjects (area under the receiver operating characteristic curve = 0.89 ± 0.03). Linear discriminant analysis showed several bacterial species with significantly higher scores in T1D, including Prevotella copri and Eubacterium siraeum, and species with higher scores in control subjects, including Firmicutes bacterium and Faecalibacterium prausnitzii (P < 0.05, false discovery rate corrected for all). On the functional level, several metabolic pathways were significantly lower in adults with T1D. Several bacterial taxa and metabolic pathways were associated with the host's glycemic control.

conclusionsWe identified a distinct gut microbial signature in adults with longstanding T1D and associations between microbial taxa, metabolic pathways, and glycemic control indices. Additional mechanistic studies are needed to identify the role of these bacteria for potential therapeutic strategies.

Indexed as

Diabetes Mellitus, Type 1Gastrointestinal MicrobiomeAdultBlood GlucoseBlood Glucose Self-MonitoringFecesGlycemic ControlHumansBlood Glucose

Identifiers

PMID35045174
PMCPMC13053884
OpenAlexW4206137404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.